Table 2.
STAT5 inhibitors in clinical trial.
STAT5 inhibitor | Disease in clinical trial | Phase of clinical trial | ClinicalTrial.gov (USA) number |
---|---|---|---|
Pioglitazone | CML | II | NCT02888964 |
Methotrexate and sirolimus | ALL | II | NCT01162551 |
Tacrolimus | GVHD | II | NCT01927120 |
Sirolimus | |||
AT9283 | Leukemia | I | NCT01431664 |